The Valley Desk

NCT01727336 · Interventional trial

Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma

Overall registry status Terminated

Phase 2

Conditions Advanced Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov